Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

Nektar Therapeutics (NKTR)

-NasdaqGS
10.77 Down 0.29(2.62%) Apr 24, 4:00PM EDT
|After Hours : 10.77 0.00 (0.00%) Apr 24, 4:00PM EDT
Add to Portfolio
Prev Close:11.06
Open:11.04
Bid:10.51 x 500
Ask:11.78 x 1000
1y Target Est:15.64
Beta:1.46
Next Earnings Date:30-Apr-15NKTR Earnings announcement
Day's Range:10.77 - 11.19
52wk Range:10.32 - 17.53
Volume:729,027
Avg Vol (3m):1,464,000
Market Cap:1.41B
P/E (ttm):N/A
EPS (ttm):-0.43
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
NKTRDown 2.62%1.41B
BMYDown 0.30%109.67B
ENZNUp 11.69%75.99M
GSKUp 0.60%112.07B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):7.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.39
Quarterly EPS Est (Mar-15) :-0.40
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):3.45

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback